Sinil Pharmaceutical Co., Ltd. (012790.KQ)
KOSDAQ · KRW · Healthcare · Drug Manufacturers - Specialty & Generic
₩6,280 (-0.63%) as of
Key statistics
- Market cap
- 72.59B
- Dividend yield
- 3.09%
- 52-week range
- 4,820.00 – 6,820.00
- Beta
- 0.48
- Revenue (TTM)
- 86.82B
- Profit margin
- 7.39%
- Volume
- 1.97k
About Sinil Pharmaceutical Co., Ltd.
Sinil Pharmaceutical Co., Ltd. manufactures and sells pharmaceutical products in South Korea and internationally. It offers pharmaceutical products for various indications, such as pain reliever, anti-inflammatory, hyperlipidemia, skin disease, and folic acid deficiency; and general/specialty drugs, veterinary drugs, and OEM products for various diseases. The company also provides cosmetics, including skin care products, etc.; health functional products comprising vitamin supplements; and quasi-drugs for yellow dust, bacteria blocking, etc. In addition, it is involved in the real estate rental services. The company was founded in 1971 and is headquartered in Chungju-si, South Korea.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Headquarters
- Chungju-si, South Korea
Financial statements (income statement, balance sheet, cash flow) and an interactive price chart are available on this page with JavaScript enabled.